Interventional Cardiologist Head of Innovation
Universite libre de Bruxelles
Westmount/ Montreal, Quebec, Canada
Full Professor of Cardiology
Cardiology Department
MUHC McGill University
&
Visiting Professor Katowice, Poland.
&
CEO CORSOL BV Advisory Company in Cardiovascular Medicine
COMBINE TRIAL Lancet ,
Co-PI COMPARE 2 trial LANCET,
PI COMPARE ACUTE trial. NEJM
CO-Designed the first network metanalysis (Bayesian comparison analysis) on DES comparison. BMJ.
DAPT-STEMI trial (PI), BMJ
REDUCE trial (trial director), Eurointervention..
{PI) COMBINE Trial EHJ
(PI) BVS –Absorb DM Benelux (PI) and France register. Cardiovascular Diabetology.
(PI) TCW trial (PI) FFR-guided PCI and TVAI vesrsus CABG and This international randomized trial is now enrolling.
(PI) ONYX ONE OCT study. Advances in Interventional Cardiology.
CO-PI ONYX-ONE trial: NEJM.
PI RFR guided-CABG trial, a multicenter international trial. Trial is ongoing.
PI The COMBINE INTERVENE trial A global trial that focus on treatment of vulnerable plaque.
Disclosure information not submitted.
What are the Dangerous Vulnerable Plaques and Treatment Options | Lessons from COMBINE-INTERVENE
Sunday, March 9, 2025
10:07 AM – 10:15 AM ET
CLINICAL TRIALS TO DETECT VP FINDINGS AND INTERPRETATION
Sunday, March 9, 2025
10:23 AM – 10:47 AM ET
Debate Discussion with Moderators
Sunday, March 9, 2025
11:03 AM – 11:15 AM ET
Panel Discussion | Atherosclerosis Therapeutic Options and Management - What is Promising?
Sunday, March 9, 2025
12:03 PM – 12:15 PM ET
Treatment of Concomitant Coronary Disease in Patients with AS
Sunday, March 9, 2025
8:24 AM – 8:32 AM ET
Panel Discussion | What Do We Need to Know on Lifetime Management?
Sunday, March 9, 2025
9:28 AM – 9:45 AM ET
TREATMENT OF CONCOMITANT CORONARY DISEASE IN PATIENTS WITH AS
Monday, March 10, 2025
1:45 PM – 2:45 PM ET
Concomitant CAD and AS is Better Treated Percutaneously
Monday, March 10, 2025
1:52 PM – 1:59 PM ET